MicroLight offers a non-invasive, non-addictive approach to pain management that is completely safe with no side effects. Established in 1990, MicroLight Corporation of America is a pioneer in cold laser therapy as the first company with FDA clearance to market low-level laser therapy (LLLT) for the non-surgical treatment of pain through adjunctive therapy.
More than 30 years of research and 600+ published studies indicate that our 830nm range is the optimal wavelength for treating pain and inflammation. Countless clinicians have trusted our unique science to treat their patients and themselves for over 20 years.